Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma

While patients with resectable pancreatic ductal adenocarcinoma (PDAC) show improved survival compared to their non-resectable counterparts, survival remains low owing to occult metastatic disease and treatment resistance. Liquid biopsy based on circulating tumor cells (CTCs) and cell-free DNA (cfDN...

Descripción completa

Detalles Bibliográficos
Autores principales: Dopico, Pablo J., Le, Minh-Chau N., Burgess, Benjamin, Yang, Zhijie, Zhao, Yu, Wang, Youxiang, George, Thomas J., Fan, Z. Hugh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028387/
https://www.ncbi.nlm.nih.gov/pubmed/35448266
http://dx.doi.org/10.3390/bios12040206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028387/
https://www.ncbi.nlm.nih.gov/pubmed/35448266
http://dx.doi.org/10.3390/bios12040206

Ejemplares similares